New Tool Can Help Physicians, Patients Monitor Cognitive Decline
the Neurology Advisor take:
A tool developed by researchers from the Regenstrief Institute and Indiana University Center for Aging Research may be able to monitor and detect cognitive, functional and psychological changes in older adults, allowing physicians to monitor a patient’s progress or decline.
The Health Aging Brain Care (HABC) Monitor analyzes 27 items on a four-point scale and includes caregiver and self-report versions that can be completed online or with paper and pencil in about three minutes. The tool includes questions about repeating processes, forgetfulness, cooking, taking medications, physical activity, hallucinations, and feelings of anxiousness and fear.
While physicians at the Center for Aging Research have already been using the tool for two years, researchers validated the patient self-report version in a study published in December. In the study, the HABC monitor demonstrated "good reliability and validity as a clinically practical multidimensional tool for assessing and monitoring symptoms of older adults attending primary care clinics,” according to Medscape.
The study, which included 291 patients aged 65 and older, lacked longitudinal data to estimate the test-retest reliability and sensitivity of the tool over longer periods of time. The researchers suggested that a future study test the sensitivity of the tool compared to other valid tools in use, such as the Neuropsychiatric Inventory.
New Tool Can Help Monitor Cognitive Decline
A new tool may provide a simple and reliable way to detect and monitor cognitive, functional, and psychological symptoms in aging adults, according to the tool's developers, who are from the Regenstrief Institute and Indiana University Center for Aging Research, in Indianapolis.
The Healthy Aging Brain Care (HABC) Monitor "helps busy physicians accurately measure and monitor the severity of symptoms, providing valuable information that the patient's entire care team needs," Malaz Boustani, MD, MPH, notes in a statement.
"We have been using this tool in the Eskenazi Health System for more than 2 years," Dr Boustani, medical director of the Eskenazi Health Healthy Aging Brain Center, in Indianapolis, told Medscape Medical News.
Next Article in Neurodegenerative Diseases
Neurology Advisor Articles
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- Loss of Function Variants in LRRK1 and LRRK2 Not Linked to Parkinson Disease
- Smoking Promotes Disease Progression in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- ZTlido Patch for Post-Shingles Pain Launching Soon
- Managing Complications of Intrathecal Baclofen Therapy
- Deep Brain Stimulation Reduces Tremor Symptoms in Parkinson Disease
- FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid
- Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored